Papapetropoulos Spyros 4
4 · Vigil Neuroscience, Inc. · Filed Nov 22, 2022
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-11-18$14.00/sh−300$4,200→ 4,000 total - Exercise/Conversion
Stock Option Grant (Right to Buy)
2022-11-18−300→ 149,604 totalExercise: $1.89Exp: 2030-11-18→ Common Stock (300 underlying) - Exercise/Conversion
Common Stock
2022-11-18$1.89/sh+300$567→ 4,300 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.
- [F2]25% of the shares subject to this option vested and became exercisable on September 14, 2021, with the remainder vesting in 36 equal monthly installments thereafter.